Achieving the Minimum Clinically Important Difference in Japanese Orthopaedic Association Score After Surgery for Degenerative Cervical Myelopathy: Predictive Factors and Impact on Patient-Reported Outcome Measures

Study DesignProspective multicenter cohort study.ObjectivesAlthough surgery for degenerative cervical myelopathy (DCM) often improves neurological function, predicting clinically meaningful recovery remains challenging. To identify preoperative predictors of achieving the minimum clinically important difference (MCID) in the Japanese Orthopaedic Association (JOA) score and to evaluate its association with patient-reported outcomes.MethodsWe prospectively analyzed 762 patients with moderate to severe DCM (defined by preoperative JOA score <15) who underwent surgery at 10 high-volume centers in Japan, with a 2-year follow-up. MCID was defined as a ≥2.5-point improvement in JOA score. Logistic regression identified independent predictors. Outcomes included JOA score, Visual Analog Scale (VAS), the JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), and the 36-Item Short Form Health Survey (SF-36).ResultsMCID was achieved in 63.0% of patients. Independent predictors included younger age (Odds ratio = 0.973 [95% confidence interval: 0.956-0.990]; <i>P</i> = 0.002), absence of cerebrovascular (0.466 [0.224-0.960]; <i>P</i> = 0.039) and cardiac disease (0.510 [0.285-0.912]; <i>P</i> = 0.023), greater cervical lordosis (1.021 [1.004-1.037]; <i>P</i> = 0.013), lower baseline JOA score (0.547 [0.485-0.617]; <i>P</i> < 0.001), and higher JOACMEQ scores for upper extremity function (1.011 [1.000-1.022]; <i>P</i> = 0.044) and QOL (1.021 [1.009-1.033]; <i>P</i> < 0.001). MCID achievement was associated with significantly greater improvements in VAS, most JOACMEQ domains, and all SF-36 subscales.ConclusionsYounger age, absence of cerebrovascular and cardiac disease, greater cervical lordosis, lower baseline JOA score, and higher preoperative JOACMEQ scores for upper extremity function and QOL were associated with achieving MCID in JOA score.

Authors

Institutions

Publication Details

Journal
Global Spine Journal
Published
2025-08-14
DOI
https://doi.org/10.1177/21925682251370640
Citations
1
Primary Topic
Cervical and Thoracic Myelopathy
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Achieving the Minimum Clinically Important Difference in Japanese Orthopaedic Association Score After Surgery for Degenerative Cervical Myelopathy: Predictive Factors and Impact on Patient-Reported Outcome Measures

Takeshi Ikegami, Narihito Nagoshi, Kazuya Kitamura, Kentaro Ago et al.
1 citations
Global Spine Journal
Cervical and Thoracic Myelopathy
2.01
article

Achieving the Minimum Clinically Important Difference in Japanese Orthopaedic Association Score After Surgery for Degenerative Cervical Myelopathy: Predictive Factors and Impact on Patient-Reported Outcome Measures

Takeshi Ikegami, Narihito Nagoshi, Kazuya Kitamura, Kentaro Ago, Takahito Iga, Toshiki Okubo, Junichi Yamane, Kentaro Fukuda, Kota Watanabe, Kazuki Takeda, Takahiro Kitagawa, Tatsuya Yamamoto, Masahiro Ozaki, Masaya Nakamura, Satoshi Suzuki, Morio Matsumoto
article en
1 citations

Abstract

Study DesignProspective multicenter cohort study.ObjectivesAlthough surgery for degenerative cervical myelopathy (DCM) often improves neurological function, predicting clinically meaningful recovery remains challenging. To identify preoperative predictors of achieving the minimum clinically important difference (MCID) in the Japanese Orthopaedic Association (JOA) score and to evaluate its association with patient-reported outcomes.MethodsWe prospectively analyzed 762 patients with moderate to severe DCM (defined by preoperative JOA score <15) who underwent surgery at 10 high-volume centers in Japan, with a 2-year follow-up. MCID was defined as a ≥2.5-point improvement in JOA score. Logistic regression identified independent predictors. Outcomes included JOA score, Visual Analog Scale (VAS), the JOA Cervical Myelopathy Evaluation Questionnaire (JOACMEQ), and the 36-Item Short Form Health Survey (SF-36).ResultsMCID was achieved in 63.0% of patients. Independent predictors included younger age (Odds ratio = 0.973 [95% confidence interval: 0.956-0.990]; <i>P</i> = 0.002), absence of cerebrovascular (0.466 [0.224-0.960]; <i>P</i> = 0.039) and cardiac disease (0.510 [0.285-0.912]; <i>P</i> = 0.023), greater cervical lordosis (1.021 [1.004-1.037]; <i>P</i> = 0.013), lower baseline JOA score (0.547 [0.485-0.617]; <i>P</i> < 0.001), and higher JOACMEQ scores for upper extremity function (1.011 [1.000-1.022]; <i>P</i> = 0.044) and QOL (1.021 [1.009-1.033]; <i>P</i> < 0.001). MCID achievement was associated with significantly greater improvements in VAS, most JOACMEQ domains, and all SF-36 subscales.ConclusionsYounger age, absence of cerebrovascular and cardiac disease, greater cervical lordosis, lower baseline JOA score, and higher preoperative JOACMEQ scores for upper extremity function and QOL were associated with achieving MCID in JOA score.

Global Spine JournalVol. 16(2)
Keio University (JP), Kanagawa Prefectural Police Department (JP), Murayama Medical Center (JP), Shizuoka Red Cross Hospital (JP), National Hospital Organization (JP), keiyu Hospital (JP), National Defense Medical College (JP)
Openalex Percentile: Top 13%
Cervical and Thoracic Myelopathy
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.